25.04 USD
▼-1.38-5.22%
盘后 26.60 0.00%
2026-11-19
市值
$1.62B
市盈率
—
EPS
-9.13
股息率
—
52 周区间
13.50 – 44.60
成交量
268.79K
Beta
-0.86
目标价
47.88
52W 低 13.5052W 高 44.60
价格走势
公司简介
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and FcγRIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an ext...